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Human embryonic stem cells (hESCs) have great potential for clinical therapeutic use. However, relatively little is known of the
mechanisms which dictate their specificity of adhesion to substrates through adhesion proteins including integrins. Previous
observations demonstrated enhanced clonogenicity in reduced oxygen culture systems. Here, we demonstrated via antibody
blocking experiments that 𝛼V𝛽5 and 𝛼6 significantly promoted hESC attachment in 2% O
2
only, whereas blockage of CD44
inhibited cell attachment in 21% O
2
alone. Immunofluorescence confirmed expression of 𝛼V𝛽5 and CD44 in both 2% O
2
and
21% O
2
cultured hESCs while flow cytometry revealed significantly higher 𝛼V𝛽5 expression in 2% O
2
versus 21% O
2
cultured
hESCs and higher CD44 expression in 21% O
2
versus 2% O
2
cultured hESCs. Adhered hESCs following blockage of 𝛼V𝛽5 in 2%
O
2
displayed a reduction in nuclear colocalisation of Oct-4 and Nanog with little effect observed in 21% O
2
. Blockage of CD44 had
the converse effect with dramatic reductions in nuclear colocalisation of Oct-4 and Nanog in 21%O
2
cultured hESC which retained
adherence, but not in 2%O
2
cultured cells. Identification of oxygen-dependent substrate attachment mechanisms in hESCs has the
potential to play a role in the development of novel substrates to improve hESC attachment and culture.
1. Introduction
Human embryonic stem cells (hESCs), derived from the
inner cell mass of preimplantation blastocysts, have an inher-
ent capacity for indefinite self-renewal [1]. Due to their differ-
entiation capacity, immortality and immunological privilege,
hESCs hold great promise for clinical therapeutics when
used in combination with tissue engineering and regenera-
tive medicine approaches [1–3]. The single currently active
approved clinical safety trial incorporating hESCs is for age-
related macular degeneration [4, 5].
Typical in vitro expansion of hESCs involves either
direct coculture with mitotically inactivated mouse (or
human) embryonic fibroblasts (MEFs) or feeder-free meth-
ods, where preconditioned media and biological substrates
such as Matrigel are employed [1, 6]. Matrigel, a loosely
defined gel sourced from Engelbreth-Holm-Swarm tumours,
is comprised of extracellular matrix (ECM) proteins includ-
ing laminin-111, collagen IV, heparin sulphate proteogly-
cans, entactin, fibronectin, growth factors, matrix-degrading
enzymes and their inhibitors, and other yet to be defined
components [6]. Limitations of culturing hESCs using
Matrigel (and other biological substrates) include batch to
batch variability, xenogenic contamination, expression of
foreign oligosaccharide residues, and scale-up issues [7, 8].
Alternatives include collagen IV, fibronectin, laminin, vit-
ronectin [9], recombinant vitronectin [8], human serum con-
taining medium conditioned by human embryonic fibrob-
lasts derived from hESCs [10], and hyaluronic acid hydrogels
[11].
hESCs ECM attachment is primarily mediated by inte-
grins (heterodimeric, transmembrane glycoproteins) and
other surface receptors [12]. The integrin family, comprised
of 18 alpha (𝛼) subunits and 8 beta (𝛽) subunits, has 24 recog-
nised distinct heterodimer arrangements each with a specific
set of functions [12–14]. Integrin functions includemediating
cell-cell, cell-ECM, and cytoskeletal-ECM interactions. ECM
proteins essential for hESC adhesion and pluripotency reten-
tion include laminin-111, collagen IV, fibronectin, and vit-
ronectin [15]. Laminin is an essential component of virtually
all basement membranes [16]. Laminin functions include the
mediation of cell adhesion, cell spreading, cell migration, and
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cell proliferation. The laminin-specific integrin receptor is
𝛼6𝛽1 while 𝛼1𝛽1, 𝛼2𝛽1, and 𝛼3𝛽1 are also recognised in a non-
specificmanner. Integrin subunits and heterodimers detected
on the surface of hESCs include 𝛼2, 𝛼3, 𝛼5, 𝛼6, 𝛼11, 𝛽1, and
𝛼V𝛽5. These subunits can heterodimerise to form receptors
for fibronectin (𝛼5𝛽1), vitronectin (𝛼V𝛽5), collagen and
laminin (𝛼2𝛽1), laminin-111 (𝛼6𝛽1), and collagen, laminin,
and VCAM1 (𝛼9𝛽1) [8, 17–19]. Antibody-directed blockage
of the 𝛼5𝛽1 heterodimer impacted hESC attachment across
a range of defined substrate coatings including collagen IV,
laminin, and entactin, when cultured with MEF-conditioned
media, demonstrating that fibronectin was secreted by feeder
cells which subsequently adsorbed onto surfaces promoting
hESC adherence [8]. In defined media (mTeSR1), blocking
𝛼5𝛽1 had no effect on hESC attachment to a vitronectin-
coated substrate but hindered adhesion to all other ECMpro-
tein substrates (laminin, entactin, and collagen IV), suggest-
ing that hESC substrate adhesion via 𝛼V𝛽5 was essential for
expansion of hESCs when cultured using defined media [8].
To this point, however, there are very few reports which
have explored the role, if any, that oxygen concentration has
on integrin expression level in hESC. Reports from mouse
embryonic stem cells (𝛽1), human mesenchymal stem cells
(hMSC) (𝛼1, 𝛼3, 𝛼5, 𝛼6, 𝛼11, 𝛼V, 𝛽1, and 𝛽3), and chondro-
cytes (𝛽1) have indicated that specific integrin subunits, indi-
cated in parentheses, display an oxygen sensitivity, hypoxia
inducible factor 1-dependent in some instances, resulting
in selected increased transcriptional expression of indicated
subunits [20, 21]. Reports have also indicated that reduced
oxygen culture has resulted in selected transcriptional down-
regulation of integrin subunits, indicated in parentheses, in
hMSC (𝛼2), trophoblast (𝛼1, 𝛼4, and 𝛼5), breast carcinoma
cells (𝛼5), gastric cancer cells (𝛼5), cytotrophoblasts (𝛼6), and
melanoma cell lines (𝛼V, 𝛽1, and 𝛼V𝛽3) [22–28].
Previous studies of the effects of reduced oxygen on hESC
culture have demonstrated enhanced clonogenicity, reduced
chromosomal aberration frequency, and improved consis-
tency of embryoid body formation, significant transcriptional
alterations, and permissive single-cell derived progenitor
isolation [29, 30]. A previous study by our group described
reduced transcriptional heterogeneity between hESC lines
(H1, H9, and RH1) cultured in physiological normoxia which
was accompanied by significant upregulation, but with mod-
est fold change differences, of specific integrin subunits (𝛼6,
𝛼E, 𝛼V, and 𝛽5) in comparison to hyperoxia (21% O
2
) [31].
We have now extended these observations and described
the translational consequences of physiological oxygen on
integrin subunit dependency and CD44 reliance for adhesion
and pluripotent marker expression, in hESC (SHEF1). We
demonstrate that adhesion, pluripotent marker expression
and localisation in hESCs were 𝛼V𝛽5 dependent in 2% O
2
and CD44 dependent in 21% O
2
. These findings will help
drive the future development of novel substrates to improve
hESC attachment and expansion during in vitro expansion.
2. Materials and Methods
2.1. Human Embryonic Stem Cell Culture. Conditioned cul-
ture media were prepared usingmouse embryonic fibroblasts
(MEFs) as previously described [6]. In brief, hESC media
comprised Knock-out DMEM (KO-DMEM) (Gibco-Invi-
trogen, UK) supplemented with 20% Knock-out Serum
Replacement (Gibco-Invitrogen, UK), 1% L-glutamine
(Lonza, UK), 1% nonessential amino acids (Lonza, UK),
4 ng/mL basic fibroblastic growth factor (Lonza, UK), and
0.1mM 𝛽-mercaptoethanol (Gibco-Invitrogen, UK). hESC
media were conditioned overnight on semiconfluent MEFs
and then further supplemented with 4 ng/mL of bFGF and
sterile filtered (Millipore, Watford, UK) before use [6].
hESCs (SHEF1) were cultured on Matrigel (BD Biosciences,
Oxford, UK) coated flasks in two different oxygen tensions;
2% O
2
(using the SCI-TIVE workstation; Ruskinn, Pencoed,
UK) and 21% O
2
(Heraeus Cytoperm 2 incubator; Thermo
Electron Corporation, UK). Media were changed on a
daily basis and cells passaged every 2-3 days after reaching
90% confluence using a brief 0.25% trypsin and EDTA
treatment for 1-2 minutes at room temperature, followed by
centrifugation for 3 minutes at 1200 rpm and replated at a
1 : 2 ratio.
2.2. Integrin Blocking and Cell Attachment. hESCs were
pretreated with blocking antibodies raised against inte-
grin subunits including anti-integrin 𝛼V (R&D Biosystems,
Abingdon, UK), anti-integrin 𝛼V𝛽5 (Chemicon Interna-
tional, Watford, UK), anti-integrin 𝛽5 (R&D Biosystems,
Abingdon, UK), anti-integrin 𝛼E (Lifespan Bioscience, Not-
tingham UK), anti-integrin 𝛼6 (Autogen Bioclear, Calne,
UK), and anti-CD44 (HCAM) (Santa Cruz Biotechnology,
Heidelberg, Germany). hESCs were incubated with either 0,
1, or 25𝜇g/mL concentrations of antibody (in PBS) in either
2% O
2
or 21% O
2
at 37∘C for 30 minutes in KO-DMEM.
Cells were then re-plated into Matrigel coated 6-well plates
at a density of 4 × 105 cells per well and incubated at either
2% O
2
or 21% O
2
for 24 hours. After 24 hours, cells were
trypsinised (as described above) and counts recorded with a
haemocytometer. Cell viability and nontoxicity of antibody
solution were determined by staining hESCs with Trypan
Blue at a 1 : 1 ratio to cell solution.
2.3. Immunofluorescence Staining. hESCs (400 000 cells/
well) were seeded onto Matrigel coated 24-well plates and
expanded to approximately 70% confluence in both oxygen
concentrations (2% O
2
and 21% O
2
). Media were removed
and the cells were fixed in 4% paraformaldehyde (in PBS) for
40minutes. Cells were washed with PBS and nonspecific pro-
teins were blocked with 3% bovine serum albumin for 1 hour
at room temperature. Cells were incubated with 50𝜇g/mL
anti-𝛼V𝛽5 anti-human monoclonal antibody solution at
4∘C overnight. Primary antibody binding was visualised
by incubation with donkey anti-human IgG (NL557; R&D
Biosystems), at 5 𝜇g/mL for 2 hours at room temperature.
Nuclei were visualised by counterstaining with DAPI and
mounted with Vectashield (Vector Laboratories, Burlingame,
CA). Images were recorded on a fluorescent microscope
(Nikon TZ1; Leica, Germany).
To assess expression of pluripotency-associated proteins
after antibody blocking, cells were first fixed (as above)
and subsequently incubated with 1 𝜇g/100 𝜇L of either goat
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anti-Nanog, goat anti-Oct-3/4, mouse anti-alkaline phos-
phatase, or mouse anti-SSEA-4 monoclonal antibody solu-
tions (SC008; R&DBiosystems, UK) at 4∘C overnight. Nanog
and Oct 3/4 binding were visualised with donkey anti-goat
IgG (NL003; R&D Biosystems) and alkaline phosphatase
and SSEA-4 were visualised with goat anti-mouse IgG
(NL557; R&D Biosystems), 5𝜇g/mL for 2 hours at room
temperature. Nuclei were visualised by counterstaining with
DAPI and mounted using Vectashield (Vector Laboratories,
Burlingame, CA). Images were recorded on a fluorescent
microscope (Nikon TZ1; Leica, Germany). To quantify the
nuclear association of Oct-4 and Nanog expression, images
were captured from five independent fields using both the
DAPI and relevant fluorochrome filters. Fields of view were
selected randomly and colocalised DAPI and either Oct-4 or
Nanog identified and expressed as a percentage of total DAPI
labelled nuclei.
2.4. Flow Cytometry. hESCs were trypsinised and fixed in
4% paraformaldehyde in PBS for 30 minutes and then
resuspended in Fluorescence activated cell sorting (FACS)
buffer (0.5% foetal bovine serum in PBS). Cells were treated
with 50𝜇g/mL 𝛼V𝛽5 and 2𝜇g/mL CD44 (1 : 500) antibodies
for 2 hours at room temperature, followed by two brief PBS
washes and incubation with goat anti-mouse IgG secondary
antibody (NL557; R&D Biosystems) at 5𝜇g/mL for a further
2 hours at room temperature. Finally, hESCs were washed
in PBS and resuspended in FACS buffer before analysis on a
FACS flow cytometer (BecktonDickinson, Oxfordshire, UK).
Data analysis was performed with the CellQuest Software
package (BD Biosciences, UK).
2.5. Statistical Analysis. Error bars on graphs indicate stan-
dard deviations (SD). Student’s 𝑡-test was performed and in
this study significance levels are indicated according to the
legend ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001.
3. Results
3.1. Integrin Subunit Gene Expression in hESC under Differ-
ing Oxygen Concentrations. Previous reports have detailed
widespread transcriptional alterations as a consequence of
culturing hESC in reduced oxygen environments [30, 34].
We performed a further analysis of our existing data set
to determine the expression levels of integrin subunits,
specifically (see SupplementaryData in SupplementaryMate-
rial available online at http://dx.doi.org/10.1155/2013/729281).
Data revealed that integrin subunits, 𝛼D (𝑃 < 0.05); 𝛽1
binding protein, 𝛽3 binding protein, 𝛽4 binding protein, 𝛼5,
𝛼9, and 𝛽1 (all 𝑃 < 0.01); and 𝛼6, 𝛼E, 𝛼V, and 𝛽5 (all
𝑃 < 0.001), were expressed significantly higher in hESCs
cultured in 2%O
2
when compared to 21%O
2
(Supplementary
Figure 1).Theorder of relative intensity fold change (FC)with
significance of 2% O
2
over 21% O
2
cultured hESCs was 𝛼D
(1.81 FC),𝛼V (1.64),𝛼9 (1.54 FC),𝛼5 (1.35 FC),𝛼6 and𝛼E (1.31
FC), 𝛽4 binding protein (1.26 FC), 𝛽1 and 𝛽1 binding protein
1 (1.20 FC), and 𝛽5 (1.16 FC) and 𝛽3 binding protein (1.09 FC)
(Supplementary Table 1). Importantly, with one exception,
(𝛼D) all significant expression changes were associated with
FC’s of <2 and would, therefore, lie out with the conventional
and arbitrary remit of inclusion in microarray-based analysis
[32]. In this instance we elected to perform a nonbiased
inclusion approach where significant changes in expression
between parameters (21% O
2
and 2% O
2
) were the solitary
inclusion criteria.
3.2. The Effect of Receptor Blocking on hESC Attachment.
Integrin subunits, 𝛼6, 𝛼E, 𝛼V, and 𝛽5, displayed highly
significant changes in expression between 2% O
2
and 21% O
2
and were selected for evaluation in a cell attachment study.
CD44 (Hyaluronan receptor) was selected based on our
earlier observations which described significantly reduced
FACS detection of CD44 in 2% O
2
versus 21% O
2
cultured
H1and H9 hESC [33]. Receptor blocking using specific
antibodies was performed to determine the effect on hESC
adhesion in both 2%O
2
and 21%O
2
(Figure 1). Blockage of𝛼6
significantly reduced hESC attachment to Matrigel in 2% O
2
with increasing antibody concentration but had no observed
effect in 21% O
2
(Figure 1(a)). Blocking of 𝛼E significantly
hindered hESC attachment to Matrigel, in both oxygen
environments (2% and 21% O
2
) (Figure 1(b)). No significant
inhibition of hESC attachment toMatrigel was observed after
blocking the 𝛼V subunit or the 𝛽5 subunit, in either 2% or
21% O
2
(Figures 1(c) and 1(d)). However, blocking the 𝛼V𝛽5
integrin demonstrated a significant reduction in hESC attach-
ment to Matrigel in 2% O
2
only (Figure 1(e)). Interestingly,
blockage of CD44 receptor showed a significant reduction
in hESC attachment to Matrigel in 21% only (Figure 1(f)).
Data normalisation to control cultures (calculated by dividing
concentration/dosage value by control value to establish
comparative values) confirmed that statistically significant
reductions in hESC attachment occurred in 2% O
2
after
blocking 𝛼V𝛽5 and 𝛼6 (𝑃 < 0.05), and hESC attachment in
21% O
2
was only inhibited after blocking CD44 (𝑃 < 0.05).
Blocking of 𝛼E inhibited hESC attachment in both 2% and
21% O
2
(𝑃 < 0.001) (Figure 1(g)). Due to the robust and
distinct impacts on adherence of both 𝛼V𝛽5 and CD44, we
next sought to determine if transcriptional alterations were
reflected at the translational level.
3.3. 𝛼V𝛽5 and CD44 Receptor Immunofluorescence and Flow
Cytometry Analysis. Positive expression of 𝛼V𝛽5 and CD44
receptors was immediately apparent in both O
2
concentra-
tions at apparently differing levels (Figures 2(a) and 2(b)).
In 21% O
2
, the expression of CD44 appeared predominantly
membrane bound and less abundant in the cytoplasmic and
nuclear regions, whereas the converse was apparent in 2%O
2
cultured cells (Figure 2(b)). The expression pattern of 𝛼V𝛽5
in 2% O
2
and 21% O
2
appeared broadly similar with stronger
staining in the former. Flow cytometry analysis revealed a 2-
fold increase in 𝛼V𝛽5 expression in hESCs cultured in 2%O
2
(64.5%) compared to 21%O
2
(32%) (𝑃 < 0.029) (Figure 2(c)).
In support of our earlier observation, we also noted that a
significantly higher percentage of hESCs cultured in 21% O
2
(72.6%) expressed CD44 (1.4-fold) relative to 2%O
2
cultured
cells (52.7%) (𝑃 > 0.037) (Figure 2(d)).
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Figure 1: Integrin blocking effects on hESCs attachment. hESCs cultured in 2% O
2
or 21% O
2
and preincubated with anti- (a) 𝛼6, (b) 𝛼E,
(c) 𝛼V, (d) 𝛽5, (e) 𝛼V𝛽5, and (f) CD44 antibodies. (𝑛 = 6); ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001. 𝑦-axis indicates % of input cell
attachment 24 hours after antibody blocking. Black and open bars indicate % of cell attachment in 2%O
2
and 21% O
2
after antibody blocking
treatment, respectively. Error bars indicate standard deviations (SD). (g) Cell attachment data normalised to unblocked controls. Asterisks
indicate significant differences to unblocked controls. Values indicate mean percentage of cell attachment (𝑛 = 6); ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and
∗∗∗
𝑃 < 0.001.
3.4. PluripotentMarker Expression in𝛼V𝛽5 andCD44Blocked
hESCs. Immunostaining demonstrated that hESCs which
retained a capacity for substrate adhesion after either 𝛼V𝛽5
or CD44 blockage in hESCs cultured in 2%O
2
or 21%O
2
had
distinct effects on their pluripotentmarker location. Adhered
hESCs after 𝛼V𝛽5 blockage in 21% O
2
retained nuclear
colocalisation of Oct-4 and Nanog (Figure 3), whereas, in
2% O
2
, a 3.44-fold reduction in nuclear colocalisation of
Oct-4 and a 3.63-fold reduction for Nanog were appar-
ent (Figures 3 and 4). Similarly, an overall decrease in
cytoplasmic expression of ALP and SSEA-4 was noted for
hESC which had retained a capacity for substrate adherence
in 2% O
2
in comparison to 21% O
2
after 𝛼V𝛽5 blockage
(Figure 3).
hESC which retained adherence after antibody blockage
of CD44 in 2% O
2
retained nuclear colocalisation of Oct-
4 and Nanog, whereas, in 21% O
2
, a 3.62-fold decrease in
nuclear colocalised Oct-4 and a 3.4-fold decrease in Nanog
were observed (Figures 3 and 4). Furthermore, an apparent
overall decrease in expression levels of ALP and SSEA-4 was
also observed in adhered hESCs, cultured in 21% O
2
, in
comparison to 2% O
2
after CD44 blockage (Figure 3).
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Figure 2: 𝛼V𝛽5 and CD44 expressions in hESC. (a) Immunoflourescent staining of 𝛼V𝛽5 integrin and (b) CD44 (HCAM) in hESCs cultured
in both 2% O
2
and 21% O
2
. Scale Bar = 100𝜇m. Flow cytometry quantification of (c) 𝛼V𝛽5 integrin expression and (d) CD44 receptor
expression, in hESCs cultured in both 2% and 21% O
2
environments. (𝑛 = 5); ∗𝑃 < 0.05. 𝑦-axis indicates % of hESCs with positive receptor
expression. Black and open bars indicate 2% O
2
and 21% O
2
, respectively. Error bars indicate standard deviations (SD).
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Figure 3: Pluripotent marker expression in 𝛼V𝛽5 blocked hESCs and CD44 blocked hESCs. Immunoflourescent staining of pluripotent
marker expression (Oct-3/4, Nanog, ALP, and SSEA-4) in hESCs, 24 hours after 𝛼V𝛽5 blockage and CD44 blockage when cultured in 2% O
2
or 21% O
2
. Nuclei are counterstained with DAPI (indicated in blue). Scale bar = 100𝜇m.
4. Discussion
Pluripotentiality, self-renewal, and relative ease of scale-up
of hESC represent the main drivers behind regenerative
medicine industry association and potential applicability in
widespread disease treatments. Limitations behind immedi-
ate application remain and include tumorigenicity, xenogenic
risk, and poorly defined mechanisms of action. Reduction
of these limitations is associated with better understanding
of the mechanisms of substrate adhesion. We have revealed
that hESC substrate adhesion operates through integrin
dependent and independent pathways where oxygen tension
plays a key role in mechanism choice with implications for
pluripotential retention.
Integrin receptors expressed by hESC play a vital role
in adhesion to ECM proteins such as laminin (𝛼6𝛽1), vit-
ronectin (𝛼V𝛽5) and fibronectin (𝛼V𝛽1, 𝛼5𝛽1), and colla-
gen and laminin (𝛼2𝛽1), nidogen, laminin, collagen 1 and
fibronectin (𝛼3𝛽1), collagen (𝛼11𝛽1) [8, 17, 18]. It is evident,
therefore, that substantial redundancies exist across the
signalling and cell-matrix interaction pathways that are asso-
ciatedwith hESC adhesion and self-renewal. Previous reports
have detailed transcriptional alterations resulting in reduced
transcriptional heterogeneity following culture of hESC in a
reduced oxygen environment [30, 34]; this includes a study by
our group which specifically revealed that integrin subunits,
𝛼5 (𝑃 < 0.01) and 𝛼6, 𝛼E, 𝛼V, and 𝛽5 (all 𝑃 < 0.001), were
expressed significantly higher in hESCs cultured in 2% O
2
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Figure 4: Nanog and Oct-4 nuclear colocalisation after surface receptor blockage. Quantification of nuclear-associated expression of Oct-4
and Nanog expression in hESCs which retained substrate adhesion after (a) 𝛼V𝛽5 blockage in either 2% O
2
or 21% O
2
cultured hESC and (b)
CD44 blockage in either 2% O
2
or 21% O
2
cultured hESC. ∗∗∗𝑃 < 0.001. 𝑦-axis indicates % of nuclear colocalisation.
when compared to 21% O
2
(see Supplementary Figure 1 and
Supplementary Table 1) [31]. Furthermore, previous reports
have detailed a reliance on 𝛼V𝛽5 and 𝛼6 integrin subunits
for hESC attachment in 21% O
2
[7, 8], which differs from our
observations where significant alterations in integrin gene
expression, attachment rates, and surface-bound receptor
were observed in 2%O
2
only. However, the remit of these pre-
vious investigationswas not to compare the effects of different
oxygen environments on the reliance of𝛼V𝛽5 and𝛼6 integrin
subunits for hESC attachment and thus may have observed
even greater significant differences when investigated under
2%O
2
.The concentration of antibody blocking solution used
for 𝛼6 in the study byMeng et al., 2010, was also much higher
(10mg/mL) in comparison to the concentration range used
in this study (0–50 𝜇g/mL) [7]. In our study, we did notice
variation in control attachment numbers for untreated cells
(Figures 1(a)–1(f)). In our experience, multiple factors can
affect attachment including Matrigel and conditioned media
used at the time of each experiment. For example, variations
in Matrigel lot or MEF-conditioned media batch could result
in different concentrations of proteins relative to each other,
which could subsequently have an effect on the availability of
appropriate ligands for corresponding hESC surface integrin
receptors. For this reason, all attachment data was performed
with an 𝑛 of 3 with each 𝑛 incorporating 3 experimental
repeats normalised to the corresponding control attachment
values for each integrin data set, in order to validate the
significance in the change of integrin expression as a result
of oxygen environment.
CD44 is a specific receptor and mediator for hyaluronic
acid (HA), which promotes hESC proliferation and associ-
ated intracellular pathways [11, 32]. HA, secreted by MEFs
(feeder cells) into media at a concentration of approximately
840 ng/mL, plays a critical role in coregulation of gene
expression, signalling, proliferation, motility, and adhesion
of hESCs where levels are higher in undifferentiated hESCs
and decrease with onset of differentiation [11, 35]. Our results
provide validation and extension of recent reports in which
antibody blocking of CD44 was described as reducing hESC
clonogenicity in 21% O
2
[11, 35]. Our previous study also
noted the significant upregulation of HA-associated genes;
Hyaluronan and proteoglycan link protein 3, Hyaluronan-
mediated motility receptor, and Hyaluronoglucosaminidase
2 in 21%O
2
(see Supplementary Table 1). Taken together with
our previous observations, these data strongly suggest that
oxygen signalling has a role in defining substrate adhesion
mechanistic choice. In hypoxia, there is a downregulation
in the expression of hyaluronic acid associated genes: and
blockage of the CD44 receptor in 2% O
2
had little effect
on cell attachment. This demonstrates the clear switch in
the reliance of a specific receptor for hESC attachment in
different oxygen environments, in this case, being CD44
in 21% O
2
to 𝛼V𝛽5 in 2% O
2
. Although microarray data
has demonstrated that transcription of CD44 is not hypoxia
repressible, it appears that translation of CD44 is repressible
suggesting that themessage is not being relayed into a protein,
in 2%O
2
. Further studies are required to elucidate the precise
mechanisms underlying substrate choice pathways.
Interference with substrate adhesion mechanisms had an
immediate role in maintenance of the undifferentiated state
in hESCs. Oxygen itself is a bioactive, signalling molecule
which, in conjunction with other regulatory factors, can
influence various cellular activities including cell attachment
and proliferation as well as intracellular pathways which
are involved in controlling stemness. Hypoxia inducible
factors interact with integrins and growth factor signalling
which are also strongly interlinked and act in combination.
The activation of these pathways is crucial in maintaining
pluripotency of hESCs, through mechanisms which are yet
to be clearly defined [35]. Antibody blockage of 𝛼V𝛽5
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(in 2% O
2
) and CD44 (in 21% O
2
) significantly decreased
the nuclear localisation of Oct-3/4 and Nanog which strongly
suggests an oxygen-linked substrate adhesion mechanism
choice pathway. To function as pluripotency regulators,
Nanog andOct-3/4 require nuclear colocalisation [36]. In this
instance, nuclear localisation was lost as a direct consequence
of substrate adhesion receptor blockage in an oxygen-specific
manner. In addition to these, a substantial decrease in
Alkaline phosphatase and SSEA-4 expression was also noted
in both. The consistency of response indicates that either
𝛼V𝛽5 orCD44 is signalling via similar pathways, for instance,
interfering with FGF-2 signalling pathway resulting in inacti-
vation of pathways MAPK/ERK, PI3/AKT kinase, and NFkB
or through distinct, though mechanistically identical, self-
renewal maintenance pathways [37, 38]. More specifically, in
2%O
2
, HIFs are able to activate signalling pathways including
FGF and notch through upregulating the expression of tran-
scriptional factors such as NFkB, activator protein-1, p53, and
C-myc [39, 40]. Therefore, it is apparent that the inhibition
of receptor 𝛼V𝛽5 results in the outside-in signalling effect
resulting in the inactivation of these intracellular pathways
which cause the inactivation in the expression of pluripotent
genes. As for CD44, we believe that blocking this receptor in
21%O
2
interferes with the FGF-2 signalling pathway which is
known to cause inactivation ofMAPK, ERK, PI3/AKTkinase,
andNFKBpathwayswhich has been evidently shown to cause
a downregulation of pluripotent markers.
Recognition of the specific integrin mediators and ECM
proteins, required for hESC attachment and growth whilst
retaining pluripotency, is fundamental for scaling up cul-
turing protocols for potential therapeutic applications. Con-
current research has attempted to implement these find-
ings into designing or investigating alternate defined sub-
strates to Matrigel for hESC culture coupled to elimination
of xenogenic contamination. Recent studies have defined
individual ECM proteins such as laminin, vitronectin,
fibronectin, and collagen as alternative hESC culture sub-
strates [8]. Uniquely, we have demonstrated in this study
that oxygen is an additional factor that drives the substrate
adhesion ability of hESCs. The definition of essential hESC
integrin receptors in relation to oxygen will enable the effec-
tive and constructive design of novel engineered substrates
(synthetic or natural) which would present tailored ligand
sites for corresponding hESC receptors resulting in enhanced
hESC attachment and self-renewal at an enhanced rate with
the elimination of xenogenic substrates. The development of
defined substrates will enhance the definition and standardis-
ation of hESC culture and assist in clinical translation of hESC
products.
5. Conclusion
hESC substrate-attachment mechanisms are related to the
oxygen environment in which hESCs are cultured.This study
describes the specific, key integrins and adhesion molecules
which mediate this function in an oxygen concentration-
dependent manner. These data will assist in the design of
novel substrates with the potential to eliminate xenogenic
substrate components and promote hESC adhesion in
the relevant oxygen environments. The optimised oxygen
environment, nonbiologicial xeno-free substrate, and defined
media would result in a simpler, in vitro hESC culture
technique and improve the scale-up of hESCs, which could
provide exciting opportunities for in vivo cell therapy and
regenerative medicine applications.
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